← Eichor
Study identifier: NCT06614010 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Effect of Different Administration Routes of Dexmedetomidine Combined with Ultrasound-Guided Fascia Iliaca Block on Emergence Agitation After Hip Replacement Surgery

Condition: Dexmedetomidine · Fascia Iliaca Block  ·  Sponsor: Qianfoshan Hospital

PhasePhase 1
Planned participants207
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

To examine the impact of various administration routes of dexmedetomidine in conjunction with ultrasound-guided fascia iliaca block (FIB) on emergence agitation (EA) during the postoperative recovery period after hip replacement surgery.

This description comes directly from the study's public registry record.

Talk to the study team

Pengcai Shi, Chief physician  ·  13791126828  ·  shipc1997@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Qianfoshan HospitalJinan, Shandong, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06614010